H.R. 1349 · 119th Congress
Women’s Protection in Telehealth Act
- Stage
- In committee
- Sponsor
- W. Steube
- Introduced
- 2025-02-13
- Latest action
- 2025-02-13 · Introduced in House
Summary
Women’s Protection in Telehealth Act
This bill excludes providers of abortion-inducing drugs from participating in Medicare unless the provider is a physician who physically examines the patient, is physically present when the drug is administered, and schedules an in-person follow-up visit with the patient within 14 days of administering the drug.